BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8572637)

  • 1. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
    Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
    J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
    Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of flow cytometry in the prognosis of tumors of the kidney in adults].
    Sibert L; Laquerrière A; Czernichow P; Dadoun D; Hemet J; Grise P
    Ann Urol (Paris); 1989; 23(6):476-81. PubMed ID: 2694924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
    Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
    Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
    al-Abadi H; Nagel R
    Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
    Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
    Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
    Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
    Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.